Project Grant K08AI193170
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $493,889 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026, through March 31, 2031. The award supports investigator-initiated biomedical research to elucidate the mechanisms underlying food-specific immunoglobulin E (IgE) antibody induction in the gastrointestinal...
- Federal Project Grant Award Summary Northwestern University received a $106,922 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 26, 2026, with completion targeted for October 31, 2028. The award supports fundamental biomedical research investigating the role of cysteinyl leukotrienes as mediators of food allergen absorption across the intestinal barrier and...
- Federal Project Grant Award Summary Yale University received a $105,402 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 27, 2026, with a completion date of April 15, 2029. The award supports investigator-initiated biomedical research focused on understanding the mechanisms of resilience to cytokinopathy flares in autoinflammatory diseases. The research addresses...
- Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $250,000 to the University of Michigan under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 21, 2025, for research aimed at developing diagnostic and prognostic tools for food allergies. The project, which concludes on July 31, 2026, focuses on creating an immunological niche (IN) scaffold technology to identify immunological markers that distinguish between mild and severe...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Michigan a Project Grant of $746,017 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 23, 2026, with a completion date of March 31, 2031. The research project, titled "Common Myeloid Progenitor-Derived IL-9 Regulates Gastrointestinal Mast Cell Density and Food Allergy Susceptibility," investigates the immune mechanisms...
- Federal Project Grant Award Summary Yale University received a $778,828 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 6, 2026, with a completion date of March 31, 2031. This award supports investigator-initiated research examining novel loss-of-function gene variants in ZFYVE21 and their role in dysregulated innate immunity. The research deliverables include...
- Federal Grant Award Summary Yale University received a $251,938 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 9, 2026, with completion targeted for May 31, 2028. The grant supports investigator-initiated biomedical research focused on characterizing heterogeneity in autoimmune myasthenia gravis (MG) by identifying and analyzing disease variants driven by distinct immune...
- Federal Grant Award Summary Yale University received a $3.13 million Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 25, 2025, with a completion date of June 30, 2029. The grant funds investigator-initiated biomedical research focused on elucidating the mechanisms of lymphoid-specific beta-catenin protein degradation in B-lymphoid cells. The research will characterize how B-cells...
- Federal Grant Award Summary Yale University received a $735,631 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 1, 2026, with completion targeted for March 31, 2031. The research focuses on investigating the origin and functional properties of CX3CR1+ neutrophils, a novel neutrophil population with distinct biological characteristics compared to canonical neutrophils....
- Federal Project Grant Award Summary Yale University received a $2,685,326 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded July 7, 2025, with a completion date of June 30, 2029. The award supports biomedical research investigating the regulation of neutrophil plasticity, heterogeneity, and functional ambivalency by Wnt5 proteins in the context of colitis. The research focuses on...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Yale University a $188,005 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support five years of investigator-initiated biomedical research from June 5, 2026 through May 31, 2031. Principal Investigator Dr. Elise Liu, MD, PhD, an allergist-immunologist at Yale University in New Haven, Connecticut, will conduct research to elucidate the mechanisms by which invariant natural killer T (iNKT) cells regulate food-specific immunoglobulin E (IgE) production. The research addresses a significant public health challenge, as food allergies affect 32 million people in the United States with limited treatment options and no cure. The project will generate scientific knowledge regarding immune pathways that trigger food-specific IgE production through three primary research objectives: (1) determining how iNKT cell activation promotes food IgE production; (2) identifying lipids and lipid-presentation molecules that can induce food IgE production; and (3) characterizing which antigen-presenting cells activate iNKT cells and prime T follicular helper cells in the food allergy model. The research utilizes a novel α-galactosylceramide-induced food allergy mouse model to test the hypothesis that dietary or microbiome-derived lipids presented by conventional type 2 dendritic cells to pro-allergenic iNKT cells drive food-specific IgE production. These findings are intended to identify therapeutic targets for developing future food allergy interventions and support Dr. Liu's career development as an independent investigator in food allergy immunology.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $188.0k | 6/9/26 |